title: [Netilmicin in single daily doses for the bacterial bronchopulmonary complications in patients with advanced bronchogenic carcinoma].
abstract: In 40 patients with bacterial bronchopulmonary complications during polychemotherapy for advanced bronchogenic carcinoma, once-daily netilmicin (4.5 mg/kg every 24 h) brought about complete resolution of the infective process in 90% of the cases and eradication of the responsible pathogen in 82%. This result must be considered good in view of the patients' precarious condition due to their advanced neoplastic disease.
authors.forename: M
authors.initials: M
authors.lastname: Zubiani
authors.forename: M
authors.initials: M
authors.lastname: Aquilini
authors.forename: A
authors.initials: A
authors.lastname: Gagliardi
authors.forename: V
authors.initials: V
authors.lastname: Lucifora
authors.forename: M A
authors.initials: MA
authors.lastname: Mariani
authors.forename: F M
authors.initials: FM
authors.lastname: Notaro
authors.forename: G
authors.initials: G
authors.lastname: Ranieri
authors.forename: M
authors.initials: M
authors.lastname: Signora
authors.forename: L
authors.initials: L
authors.lastname: Franchino
authors.forename: F
authors.initials: F
authors.lastname: Salvati
mesh_terms: D000328:Adult; D000368:Aged; D002283:Carcinoma, Bronchogenic / Q000150:complications* / Q000382:microbiology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009428:Netilmicin / Q000008:administration & dosage / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology
chemical_list: D009428:Netilmicin
vernacular_title: La netilmicina in monodose giornaliera nelle complicanze batteriche broncopolmonari in pazienti con carcinoma broncogeno avanzato.